"Cellular Reprogramming" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A process where fully differentiated or specialized cells revert to pluripotency or a less differentiated cell type.
| Descriptor ID |
D065150
|
| MeSH Number(s) |
G04.152.262 G05.135
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cellular Reprogramming".
Below are MeSH descriptors whose meaning is more specific than "Cellular Reprogramming".
This graph shows the total number of publications written about "Cellular Reprogramming" by people in this website by year, and whether "Cellular Reprogramming" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 1 | 1 | 2 |
| 2019 | 1 | 2 | 3 |
| 2021 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cellular Reprogramming" by people in Profiles.
-
Fibroblast fate determination during cardiac reprogramming by remodeling of actin filaments. Stem Cell Reports. 2022 07 12; 17(7):1604-1619.
-
Single cell biology-a Keystone Symposia report. Ann N Y Acad Sci. 2021 12; 1506(1):74-97.
-
Prostaglandin I2 signaling licenses Treg suppressive function and prevents pathogenic reprogramming. J Clin Invest. 2021 04 01; 131(7).
-
CD38-NAD+-Sirt1 axis in T cell immunotherapy. Aging (Albany NY). 2019 10 23; 11(20):8743-8744.
-
Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity. Cell Rep. 2019 08 13; 28(7):1879-1893.e7.
-
Embryonic estrogen exposure recapitulates persistent ovarian transcriptional programs in a model of environmental endocrine disruption. Biol Reprod. 2019 01 01; 100(1):149-161.
-
Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells. PLoS One. 2015; 10(8):e0134995.
-
Evolving targeted therapies for right ventricular failure. Expert Opin Biol Ther. 2015; 15(9):1263-83.
-
Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS One. 2013; 8(5):e64496.
-
Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor. Cell Res. 2013 May; 23(5):658-72.